Clinical trial
An Open Label Study Using Consecutive Intravenous Depacon With Oral Depakote ER…
NCT00203242 · Thomas Jefferson University, Other · Completed
Key facts
| NCT number | NCT00203242 |
|---|---|
| Title | An Open Label Study Using Consecutive Intravenous Depacon With Oral Depakote ER for the Treatment of Cluster Headaches. |
| Official title | An Open-label Pilot Study to Collect/Evaluate Data on the Use of Consecutive Daily Intravenous Doses of Depacon in Combination With Daily Dose of Depakote ER During a Cluster Headache Cycle. |
| Lead sponsor | Thomas Jefferson University, Other |
| Collaborators | Abbott Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Cluster Headache |
| Intervention type | Drug |
| Interventions | Depacon IV and Depakote ER |
| Enrollment | 15 |
| Start date | Jul 1, 2003 |
| Primary completion | Sep 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Sep 20, 2005 |
| Last update posted | Jul 15, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: